Philippa A. Charlton
Papers
1
Total Citations
4
H-Index
1
About
Dr. Philippa A. Charlton is a clinical researcher specializing in gastroenterology and neurogastroenterology, with a particular focus on gastroparesis and functional gastrointestinal disorders. Her most cited work investigates the therapeutic potential of ghrelin agonists, notably through the Phase 2 clinical trial of TZP-102, which demonstrated significant correlations between symptom improvement—including nausea, early satiety, bloating, and abdominal pain—and patient-reported overall treatment effects. This research has contributed to advancing understanding of ghrelin signaling pathways in gastric motility disorders, offering hope for patients with limited treatment options. While her citation count of 4 reflects the specialized nature of early-phase clinical research, her work remains foundational for subsequent studies on ghrelin receptor agonists in gastroparesis. Dr. Charlton’s contributions highlight the importance of patient-centered endpoints in drug development, bridging mechanistic insights with real-world symptom relief. Her findings continue to inform clinical trial design and therapeutic strategies for debilitating digestive conditions.
Research Focus
Key Achievements
Top Papers
- 1